# OnCo record angiosarcoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/angiosarcoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "angiosarcoma" ;
  schema:name "Angiosarcoma"@en ;
  schema:alternateName "Haemangiosarcoma"@en, "Lymphangiosarcoma"@en, "Stewart-Treves syndrome (lymphoedema-associated angiosarcoma)"@en, "Radiation-associated angiosarcoma"@en ;
  schema:description "Angiosarcoma is an aggressive cancer of the cells that line blood and lymph vessels. It grows as bruise-like patches on the scalp of older people, in breasts treated years earlier with radiotherapy, or inside organs. Surgery and radiotherapy are used where possible, weekly paclitaxel is the most active drug, and immunotherapy helps a minority with the sun-damaged scalp form."@en ;
  schema:url <https://onco.cc/cancers/angiosarcoma/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Angiosarcoma> ;
  schema:citation <https://en.wikipedia.org/wiki/Angiosarcoma> ;
  onco:tag "subtype-page" ;
  onco:related <https://onco.cc/cancers/vascular-tumours/>, <https://onco.cc/cancers/kaposi-sarcoma/>, <https://onco.cc/cancers/epithelioid-haemangioendothelioma/> ;
  onco:pipeline <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/pazopanib/> ;
  onco:standardOfCare <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/trials/angiotax/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/pegylated-liposomal-doxorubicin/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/pazopanib/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/technologies/checkpoint-inhibitor/> .